Announcements Trials
Browse Landscape

Status

Completed 7Terminated 1

Sponsor Class

OTHER 58INDUSTRY 8FED 3OTHER_GOV 2NIH 1NETWORK 1

Study Type

Observational 8

Sponsor

Cancer Type

Breast 6Genitourinary 2Thoracic 1Plasma cell 1

Conditions

Neoplasms 3216Carcinoma, Non-Small-Cell Lung 2729Breast Neoplasms 2551Colorectal Neoplasms 1463Prostatic Neoplasms 1307Neoplasm Metastasis 1301Multiple Myeloma 1112Melanoma 1103Ovarian Neoplasms 1006Lung Neoplasms 945Recurrence 924Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 833Lymphoma, Non-Hodgkin 767Lymphoma 713Stomach Neoplasms 692Carcinoma, Renal Cell 660Carcinoma, Hepatocellular 647Leukemia, Lymphocytic, Chronic, B-Cell 560Squamous Cell Carcinoma of Head and Neck 550Lymphoma, Follicular 515Head and Neck Neoplasms 490Glioblastoma 473Small Cell Lung Carcinoma 447Lymphoma, Large B-Cell, Diffuse 440Triple Negative Breast Neoplasms 436Advanced Solid Tumors 432Leukemia 426Uterine Cervical Neoplasms 420Urinary Bladder Neoplasms 405

Interventions

Anastrozole 2Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
INDUSTRY × Patient Compliance × Clear all
NCT01103544 2015-05-13

JONAS-1

Pierre Fabre Pharma GmbH

Completed
200 enrolled
Genitourinary

Carcinoma, Transitional Cell, Patient Compliance

NCT01208779 2013-07-17

Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

AstraZeneca

Completed
90 enrolled

Patient Compliance

NCT01198457 2012-09-07

BONA

Bayer

Completed
147 enrolled
BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Osteolysis, Patient Compliance, Prostatic Neoplasms

NCT00890903 2012-07-02

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Pierre Fabre Pharma GmbH

Completed
62 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Patient Compliance

NCT00936442 2012-02-14

ARTEMIS

AstraZeneca

Completed
104 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00555867 2011-12-23

PACT

AstraZeneca

Terminated
4,923 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00523315 2011-05-20

APOLLO

AstraZeneca

Completed
862 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00878930 2011-01-05

FRAME

AstraZeneca

Completed
500 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡